Acurx Pharmaceuticals (ACXP) vs Scienture (SCNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Acurx Pharmaceuticals is the larger company by market cap ($6.9 million vs $6.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACXP | SCNX |
|---|---|---|
| Share price | $1.24 | $3.75 |
| Market cap | $6.89M | $6.16M |
| 1-day change | -0.80% | -2.85% |
| EPS (TTM) | $-2.67 | $-52.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.98 | $65.00 |
| 52-week low | $1.23 | $3.23 |
| Distance from 52-week high | -84.46% | -94.23% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +1270.97% | +900.03% |
| Average volume | 125.08K | 212.16K |
| Shares outstanding | 5.56M | 1.64M |
| Employees | 4 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Acurx Pharmaceuticals
ACXP stock →Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Scienture
SCNX stock →Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
ACXP vs SCNX FAQ
Which is bigger, Acurx Pharmaceuticals or Scienture?
Acurx Pharmaceuticals (ACXP) is larger, with a market capitalization of $6.89M compared with $6.16M for Scienture (SCNX).
Are Acurx Pharmaceuticals and Scienture in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.